Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Pain in Hallux Abducto Valgus
NCT03569098Phase 2Completed
- Sponsor
- Ipsen
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of abobotulinumtoxinA in hallux valgus, sponsored by Ipsen. Started Jun 2018; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
hallux valgus
Beyond the preview
Go deeper on NCT03569098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03569098.